Apolipoprotein E genotype and schizophrenia

Neuropsychobiology

Volumn 39, Issue 3, 1999, Pages 141-143

  Chen, Jen Yeu ^a   Hong, Chen Jee ^a,b   Chiu, Hsien Jane ^a,b   Lin, Chih Yuan ^a   Bai, Ya Mei ^a   Song, Hsiu Li ^a   Lai, Hao Che ^a   Tsai, Shih Jen ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Apolipoprotein E; Association study; Genotype; Schizophrenia

Indexed keywords

APOLIPOPROTEIN E;

ARTICLE; CONTROLLED STUDY; GENETIC RISK; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; NEUROPSYCHIATRY; PATHOGENESIS; PRIORITY JOURNAL; SCHIZOPHRENIA;

EID: 0032938520     PISSN: 0302282X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000026573     Document Type: Article

References (22)

1. Poirier J: Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease. Trends Neurosci 1994;17:525-530.
2. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA: Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993;261:921-923.
3. Harrington CR, Roth M, Xuereb JH, McKenna PJ, Wischik CM: Apolipoprotein E type epsilon 4 allele frequency is increased in patients with schizophrenia. Neurosci Lett 1995; 202:101-104.
4. Howard R, Dennehey J, Lovestone S, Birkett J, Sham P, Powell J, Castle D, Murray R, Levy R: Apolipoprotein E genotype and late paraphrenia. Int J Geriatr Psychiatry 1995;10:147-150.
5. Joober R, Rouleau G, Fon E, Lal S. Palmour R, Bloom D, Labelle A, Benkelfat C: Apolipoprotein E genotype in schizophrenia. Am J Med Genet 1996;67:235.
6. Zhu S, Nothen MM, Uhlhaas S, Rietschel M, Korner J, Lanczik M, Fimmers R, Propping P: Apolipoprotein E genotype distribution in schizophrenia. Psychiatr Genet 1996;6:75-79.
7. Arnold SE, Joo E, Martinoli MG, Roy N, Trojanowski JQ, Gur RE, Cannon T, Price RA: Apolipoprotein E genotype in schizophrenia: Frequency, age of onset, and neuropathologic features. Neuroreport 1997;8:1523-1526.
8. Powchik P, Friedman J, Haroutunian V, Greenberg D, Altsteil L, Purohit D, Perl D, Davidson M: Apolipoprotein E4 in schizophrenia: A study of one hundred sixteen cases with concomitant neuropathological examination. Biol Psychiatry 1997;42:296-298.
9. Town T, Fallin D, Crawford F, Walsh S, Solomon R, Mullan M: Lack of association between the apolipoprotein E epsilon4 allele (APOE epsilon4) and chronic schizophrenia. Am J Med Genet 1997;74:451-452.
10. Thibaut F, Coron B, Mannequin D, Segard L, Martin C, Dollfus S, Campion D, Frebourg T, Petit M: No association of apolipoprotein epsilon 4 allele with schizophrenia even in cognitively impaired patients. Schizophr Res 1998; 30:149-153.
11. Jonsson E, Lannfelt L, Engvall B, Sedvall G: Lack of association between schizophrenia and the apolipoprotein E epsilon 4 allele. Eur Arch Psychiatry Clin Neurosci 1996;246:182-184.
12. Igata-Yi R, Igata T, Ishizuka K, Kimura T, Sakamoto S, Katsuragi S, Takamatsu J, Miyakawa T: Apolipoprotein E genotype and psychosis. Biol Psychiatry 1997;41:906-908.
13. Lan TH, Hong CJ, Chen JY, Sim CB: Apolipoprotein E-epsilon 4 frequency in patients with schizophrenia. Biol Psychiatry 1997;42:225-227.
14. Wenham PR, Price WH, Blandell G: Apolipoprotein E genotypingby one-stage PCR. Lancet 1991;337:1158-1159.
15. Pickar D, Malhotra AK, Rooney W, Breier A, Goldman D: Apolipoprotein E epsilon 4 and clinical phenotype in schizophrenia. Lancet 1997;350:930-931.
16. Pitas RE, Boyles JK, Lee SH, Foss D, Mahley RW: Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins. Biochim Biophys Acta 1987;917: 148-161.
17. Mahadik SP, Mukherjee S: Free radical pathology and antioxidant defense in schizophrenia: A review. Schizophr Res 1996;19:1-17.
18. Miyata M, Smith JD: Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides. Nat Genet 1996;14:55-61.
19. Nathan BP. Bellosta S, Sanan DA, Weisgraber KH, Mahley RW, Pitas RE: Differential effects of apolipoprotein E3 and E4 on neuronal growth in vitro. Science 1994;264:850-852.
20. Ohara K, Nagai M, Ohara K: Apolipoprotein E epsilon 4 and clinical phenotype in schizophrenia. Lancet 1997;350:1857.
21. Arnold SE, Trojanowski JQ: Cognitive impairment in elderly schizophrenia: A dementia (still) lacking distinctive histopathology. Schizophr Bull 1996;22:5-9.
22. Boston PF, Dursun SM, Reveley MA: Cholesterol and mental disorder. Br J Psychiatry 1996;169:682-689.